Question

Carmella was diagnosed with stage four metastatic ovarian cancer. Upon diagnosis, it was discovered that her cancer had spread to multiple organs, her brain, and her bones. Carmella agreed to undergo an experimental treatment to attempt to slow the growth of her aggressive cancer. Carmella received this treatment for five months before she eventually died in the hospital that was giving her the treatment.

Prior to her death, Carmella agreed that after her death, her body could be autopsied by the doctors that gave her the experimental drugs. This autopsy would be conducted to evaluate the effectiveness of the medication she received. Carmella's autopsy was subsequently completed in the hospital by one of the doctors on Carmella's research team. The doctor wanted to understand the extent of Carmella's disease as well as view the impact of the treatment she received. What type of death investigation was conducted on Carmella's remains?

Answer 1

Carmella's postmortem examination was a clinical autopsy to evaluate the effectiveness of an experimental treatment for her metastatic ovarian cancer and to further medical understanding of the disease.

Step-by-step explanation:

Carmella's case involves a clinical autopsy, a procedure performed after someone's death to understand the causes and effects of diseases. During this postmortem examination, medical professionals can evaluate the extent of disease and the impact of any treatments the deceased had undergone. Since Carmella consented to have her body studied after death to assess an experimental cancer treatment, it was a planned research-based autopsy conducted by the doctors involved with her treatment. This type of investigation can provide insights into the effectiveness of medical interventions and contribute to the scientific understanding of metastatic ovarian cancer and its treatments.